Digital PCR Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
According to Fairfield Market Research, the digital PCR market is expected to grow at a compound annual growth rate (CAGR) of 10% from 2024 to 2031, reaching $182.33 million in 2024 and $354.58 million by the end of 2031. The market's expansion is fueled by strong demand for innovative diagnostic procedures and significant advancements in PCR technology.
Key Market Drivers
Technological Advancements in PCR
Digital PCR (dPCR) technology has transformed molecular biology by enabling ultrasensitive and repeatable detection and quantification of nucleic acids. Since its initial proposal by Sykes et al. in 1992 and further development by Kalinina et al. in 1997, dPCR has continually evolved. Innovations such as the Droplet dPCR SARS-CoV-2 Test Kit and the Xpert Xpress SARS-CoV-2 test have significantly contributed to market growth, particularly during the COVID-19 pandemic.
Increasing Demand for Diagnostic Tools
The rising incidence of infectious diseases and cancer globally has spurred demand for advanced diagnostic tools and therapies. Digital PCR is widely used in molecular genetic analysis, cancer detection, mutational analysis, and quantitative gene expression studies, making it an indispensable tool in modern diagnostics.
Expanding Applications in Various Fields
Beyond healthcare, digital PCR has broad applications in environmental testing, food safety, animal health, and forensic science. Its ability to provide accurate results quickly with high sensitivity and specificity has driven its adoption in these fields.
Market Dynamics and Insights
Sales Analysis and Market Outlook
The market's growth rate is expected to accelerate, with significant contributions from the development of new PCR-based consumables and reagents.
Regional Insights
United States
In 2022, the United States accounted for a significant 23.9% share of the global digital PCR market. This substantial market share is driven by major pharmaceutical and biotechnology companies leading in innovation and development. High investments in research and development (R&D) further fuel market growth. Additionally, the U.S. benefits from a well-established healthcare infrastructure and strong support from both public and private sectors for genome analysis and related research. Robust academic and research institutions also contribute to the widespread adoption of digital PCR technologies, enhancing market expansion.
China
China held a 5.7% market share of the global digital PCR market in 2022. The surge in demand for PCR tests during the COVID-19 pandemic played a crucial role in boosting the market. The government's support for R&D in healthcare and the increasing focus on precision medicine and molecular diagnostics have further propelled the digital PCR market. China's efforts to enhance its healthcare infrastructure and the growing number of biotechnology startups are expected to drive continued market growth in the coming years.
Germany
Germany commanded a dominant 24.1% share of the European digital PCR market in 2022, reflecting its strong position in the region. The country's robust R&D infrastructure and extensive collaboration within the pharmaceutical sector are key growth drivers. Germany is known for its cutting-edge research facilities and significant investments in life sciences, fostering innovation and the development of advanced diagnostic technologies. The emphasis on precision medicine, genetic research, and the integration of digital PCR in clinical and research applications contribute to its leading market position. Additionally, strategic partnerships with global biotech companies and support for startup ecosystems create a conducive environment for market growth.
Category-wise Insights
Product Segment
Instruments held the largest market share in 2022, accounting for over 70%. This segment is expected to continue its dominance due to the user-friendly nature and high demand for digital PCR tools in research applications.
End Users
Research institutes dominated the end-user segment in 2022, with a 70% market share. The increasing demand for developing novel products and understanding disease mechanisms has led to a surge in research activities using PCR technology.
Competitive Analysis
Key players in the digital PCR market are focusing on expanding their product portfolios and obtaining regulatory approvals to strengthen their market presence. Notable developments include:
Bio-Rad Laboratories, Inc.: Received approval from the US FDA for its QXDX AutoDG digital PCR System and the QXDX BCR-ABL %IS Kit.
Thermo Fisher Scientific: Unveiled a new capillary electrophoresis (CE) system for Sanger sequencing and fragment analysis.
Fluidigm Corporation: Entered into a licensing agreement with Baylor Genetics to provide NGS library prep assays for research using the Juno System.
Key Market Players Include:
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific Inc.
• Fluidigm Corp.
• Formulatrix, Inc.
• JN Medsys.
• STILLA TECHNOLOGIES
• Avance Bioscience
• Merck KGaA
• Precigenome LLC
• QIAGEN N.V.
• Sysmex Corporation
Key Segments of the Digital PCR Industry
By Product:
• Instrument
• Consumables
• Services
By End User:
• Pharmaceutical Companies
• Research Institutes
• Forensic Labs
• Agriculture Companies
By Application:
• Clinical Diagnostics
• Basic Research
• Applied Research
• Forensic Testing
By Region:
• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa
Please note: Delivery Timelines - 5 working days.
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook